Trajectories of Fasting Plasma Glucose and Risks of Chronic Kidney Disease in a General Chinese Population: A Retrospective Study

References

• Chen N, Wang W, Huang Y, et al. Community-based study on CKD subjects and the associated risk factors. Nephrol Dial Transplant. 2009;24(7):2117–2123. doi:10.1093/ndt/gfn767
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815–822. doi:10.1016/S0140-6736(12)60033-6
   PubMed Web of Science ®Google Scholar
• Spijkerman AMW, Dekker JM, Nijpels G, et al. Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the hoorn screening study. Diabetes Care. 2003;26(9):2604–2608. doi:10.2337/diacare.26.9.2604
   PubMed Web of Science ®Google Scholar
• Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012;379(9833):2279–2290. doi:10.1016/S0140-6736(12)60283-9
   PubMed Web of Science ®Google Scholar
• Watanabe H, Obata H, Watanabe T, Sasaki S, Nagai K, Aizawa Y. Metabolic syndrome and risk of development of chronic kidney disease: the Niigata preventive medicine study. Diabetes Metab Res Rev. 2010;26(1):26–32. doi:10.1002/dmrr.1058
   PubMed Web of Science ®Google Scholar
• Lucove J, Vupputuri S, Heiss G, North K, Russell M. Metabolic syndrome and the development of CKD in American Indians: the strong heart study. Am J Kidney Dis. 2008;51(1):21–28. doi:10.1053/j.ajkd.2007.09.014
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu G, Wang G, et al. Association of serum uric acid levels with the incident of kidney disease and rapid eGFR decline in Chinese individuals with eGFR > 60 mL/min/1.73 m(2) and negative proteinuria.. Clin Exp Nephrol. 2019;23(7):871–879. doi:10.1007/s10157-019-01705-w
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-00006
   PubMed Web of Science ®Google Scholar
• Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Archives of Internal Medicine. 2004;164(6):659–663. doi:10.1001/archinte.164.6.659
   PubMed Web of Science ®Google Scholar
• Jones BL, Nagin DS. A note on a stata plugin for estimating group-based trajectory models. Sociol Methods Res. 2013;42(4):608–613. doi:10.1177/0049124113503141
   Web of Science ®Google Scholar
• Nagin DS, Jones BL, Passos VL, Tremblay RE. Group-based multi-trajectory modeling. Stat Methods Med Re. 2018;27(7):2015–2023. doi:10.1177/0962280216673085
   PubMed Web of Science ®Google Scholar
• Bilous R. Microvascular disease: what does the UKPDS tell us about diabetic nephropathy? Diabetic Medicine. J Brit Diabet Assoc. 2008;25 Suppl 2:25–29. doi:10.1111/j.1464-5491.2008.02496.x
   Google Scholar
• Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–1589. doi:10.1056/NEJMoa0806470
   PubMed Web of Science ®Google Scholar
• Gerstein HC, Miller ME, Byington RP, et al.; Action To Control Cardiovascular Risk In Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545–2559.
   PubMed Web of Science ®Google Scholar
• Patel A, MacMahon S, Chalmers J, et al.; ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560–2572.
   PubMed Web of Science ®Google Scholar
• Duckworth W, Abraira C, Moritz T, et al. VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360(2):129–139. doi:10.1056/NEJMoa0808431
   PubMed Web of Science ®Google Scholar
• Zoungas S, Arima H, Gerstein HC, et al.; Collaborators On Trials Of Lowering Glucose (CONTROL) Group. Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials. Lancet Diabetes Endocrinol. 2017;5(6):431–437. doi:10.1016/S2213-8587(17)30104-3
   PubMed Web of Science ®Google Scholar
• Fox CS, Larson MG, Leip EP, Meigs JB, Wilson PWF, Levy D. Glycemic status and development of kidney disease: the Framingham Heart Study. Diabetes Care. 2005;28(10):2436–2440. doi:10.2337/diacare.28.10.2436
   PubMed Web of Science ®Google Scholar
• Vieira MB, Neves JS, Leitão L, et al. Impaired fasting glucose and chronic kidney disease, albuminuria, or worsening kidney function: a secondary analysis of the SPRINT. J Clin Endocrinol Metab. 2019;2019:1.
   Google Scholar
• Jia W, Gao X, Pang C, et al. Prevalence and risk factors of albuminuria and chronic kidney disease in Chinese population with type 2 diabetes and impaired glucose regulation: shanghai diabetic complications study (SHDCS). Nephrol Dial Transplant. 2009;24(12):3724–3731. doi:10.1093/ndt/gfp349
   PubMed Web of Science ®Google Scholar
• Levey AS, Gansevoort RT, Coresh J, et al. Change in Albuminuria and GFR as end points for clinical trials in early stages of CKD: a scientific workshop sponsored by the national kidney foundation in collaboration with the US food and drug administration and european medicines agency. Am J Kidney Dis. 2020;75(1):84–104. doi:10.1053/j.ajkd.2019.06.009
   PubMed Web of Science ®Google Scholar